U.S. Specialty Stores Stock News

NasdaqGM:OCS
NasdaqGM:OCSPharmaceuticals

Why Oculis Holding (OCS) Is Up 5.5% After Phase 3 DME Trial Milestone – And What's Next

Oculis Holding AG has completed final patient visits in both Phase 3 DIAMOND trials of OCS-01, a topical eye drop for diabetic macular edema, with topline results from over 800 patients expected by June 2026 and a potential NDA filing targeted for the Fourth Quarter of 2026. The program aims to introduce the first non-invasive DME therapy, addressing a large population of untreated or inadequately treated patients who currently rely on injection-based options. With shares rising over the...
NYSE:FRT
NYSE:FRTRetail REITs

A Look At Federal Realty (FRT) Valuation After Recent Steady Share Price Gains

Event context and recent performance snapshot Federal Realty Investment Trust (FRT) has been drawing attention after a steady run in its unit price, with recent returns near 9% over the past month and about 9% over the past 3 months. For income focused investors, the REIT’s long history of quarterly dividend increases and its US$9.8b market value sit alongside reported annual revenue of US$1.28b and net income of US$401.7m. See our latest analysis for Federal Realty Investment Trust. That...
NasdaqCM:OCGN
NasdaqCM:OCGNBiotechs

What Ocugen (OCGN)'s Strong OCU410 Phase 2 GA Data Means For Shareholders

In April 2026, Ocugen reported full Phase 2 ArMaDa clinical trial data for OCU410 in geographic atrophy secondary to dry age-related macular degeneration, showing a 46% reduction in macular lesion growth at 12 months in medium and high dose groups versus control, with no OCU410-related serious adverse events across Phase 1 and 2. This dataset highlights Ocugen’s gene-agnostic modifier gene therapy platform as a potential one-time treatment approach that could address a wide range of dry AMD...
NasdaqGS:CALM
NasdaqGS:CALMFood

The Bull Case For Cal-Maine Foods (CALM) Could Change Following DOJ Antitrust Price-Fixing Lawsuit Threat

The US Department of Justice has reportedly prepared a civil antitrust lawsuit against major egg producers, including Cal-Maine Foods, over alleged price-fixing in 2024 and 2025, heightening regulatory scrutiny of the industry. This legal threat emerges just as Cal-Maine has been emphasizing a portfolio shift toward higher-margin specialty eggs and Prepared Foods, raising questions about how future pricing practices might evolve under closer oversight. Next, we will examine how the potential...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Assessing Halozyme Therapeutics (HALO) Valuation After Recent Share Price Strength Without Major News

Halozyme Therapeutics: Event Overview and Recent Share Performance Halozyme Therapeutics (HALO) has recently drawn investor attention without a single headline event driving sentiment. This shifts focus squarely onto its share performance and fundamentals for context. The stock closed at US$69.57, with a 0.4% move over the past day, about 3.9% over the past week, and roughly 9.7% over the past month, while the past 3 months show a 1.2% decline. See our latest analysis for Halozyme...
NYSE:EBF
NYSE:EBFCommercial Services

Ennis (EBF) Q3 EPS Slowdown Tests Bullish Earnings Growth Narratives

Ennis (EBF) has just wrapped up its latest quarter with Q3 FY 2026 revenue of US$100.2 million, basic EPS of US$0.43 and net income of US$10.8 million, setting the tone for how the rest of the fiscal year is shaping up. The company has seen quarterly revenue move from US$92.7 million in Q4 FY 2025 to US$100.2 million in Q3 FY 2026. Over the same stretch, basic EPS ranged from US$0.35 to US$0.51, giving investors a clear view of how the top and bottom lines are tracking into FY 2026 and what...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

What VEON (VEON)'s US$5.16 Billion ESOP Shelf Registration Means For Shareholders

Earlier this month, VEON Ltd. filed a shelf registration for up to US$5.16 billion in common shares, covering 94,411,725 shares in connection with an ESOP-related offering. This sizable shelf capacity gives VEON flexibility to issue a large volume of equity over time, which may influence how investors assess potential dilution, capital raising plans, and employee alignment with the company’s long-term direction. Next, we will examine how this large ESOP-related shelf registration could...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Zimmer Biomet Robotics Milestone And New Tech Leadership Spark Valuation Questions

Zimmer Biomet Holdings (NYSE:ZBH) supported the nation’s first complete robotic assisted shoulder replacement in an ambulatory surgery center. The company appointed Dr. Jonathan M. Vigdorchik as Chief Science, Technology, and Medical Affairs Officer to oversee AI, robotics, and smart implant efforts. Zimmer Biomet enters this news cycle with shares at $95.48 and mixed long term returns. The stock is up 8.7% over the past 30 days and 6.1% year to date, while the 3 year and 5 year returns...
NYSE:AORT
NYSE:AORTMedical Equipment

Will FDA Approval Of NEXUS And Endospan Option Reshape Artivion's (AORT) Minimally Invasive Aortic Strategy

Artivion, Inc. recently announced that the FDA has approved the PMA for Endospan’s NEXUS Aortic Arch System, triggering a 90‑day window in which Artivion can exercise its option to acquire Endospan, supported by a US$150 million delayed draw term loan arranged in advance. NEXUS, backed by TRIOMPHE trial data showing strong one‑year outcomes in high‑risk aortic arch patients, could broaden Artivion’s presence in minimally invasive aortic repair where alternatives to open‑chest surgery have...
NYSE:VOYA
NYSE:VOYADiversified Financial

Is Voya’s Completed US$9.87 Billion Buyback Altering The Investment Case For Voya Financial (VOYA)?

Between January 1 and March 31, 2026, Voya Financial repurchased 2,068,788 shares for US$150,000,000, completing a buyback program totaling about 205.12 million shares and US$9.87 billion originally announced on March 18, 2014. This completion marks the end of a long-running capital return initiative, highlighting how materially Voya has reduced its share count over time. We’ll now examine how the completion of this long-running share repurchase program may influence Voya Financial’s broader...
NYSE:NCLH
NYSE:NCLHHospitality

Norwegian Cruise Line Revisits Philadelphia With Homeport And Valuation Questions

Norwegian Cruise Line Holdings (NYSE:NCLH) is returning to Philadelphia with new homeport sailings for the first time in 15 years. The company plans to introduce year round itineraries from the city, supported by investment in a new cruise terminal. This move expands Norwegian’s presence in the Mid Atlantic region and opens access to additional source markets along the US East Coast. Norwegian Cruise Line Holdings operates global cruise brands that compete for vacation spending against...
NYSE:BOH
NYSE:BOHBanks

Bank Of Hawaii (BOH) Net Margin Rebound Challenges Longstanding Earnings Decline Narrative

Bank of Hawaii (BOH) opened Q1 2026 earnings season on a solid footing, with Q4 2025 revenue at US$187.1 million and basic EPS of US$1.40 backed by net income of US$55.7 million and a trailing twelve month earnings increase of 34.6%. Over recent quarters, revenue has moved from US$159.5 million in Q4 2024 to US$187.1 million in Q4 2025. Basic EPS has shifted from US$0.86 to US$1.40, against a backdrop of a higher net profit margin of 26.2% over the last 12 months versus 21.9% previously. For...
NYSE:SO
NYSE:SOElectric Utilities

Southern Battery Storage And Solar Project Adds New Layer To Growth Story

Southern Company (NYSE:SO) subsidiary PowerSecure is partnering with Powder River Energy Corporation and the NRTC on a utility scale battery energy storage and solar project in Wyoming. The project aims to combine large scale storage with solar generation to support grid reliability and growing power demand. The initiative reflects Southern Company's focus on clean energy solutions and grid resiliency within its broader portfolio of regulated utilities and energy services. For you as an...
OTCPK:FMBL
OTCPK:FMBLBanks

Farmers & Merchants Bank (OTCPK:FMBL) Net Interest Margin Rise Tests Bearish Narratives

Farmers & Merchants Bank of Long Beach (FMBL) has opened Q1 2026 earnings season with recent quarterly numbers that include Q4 2025 total revenue of US$79.1 million and basic EPS of US$160, alongside trailing 12 month EPS of about US$560 on revenue of US$293.2 million. Over recent quarters the bank has seen revenue move from US$56.6 million in Q4 2024 to US$79.1 million in Q4 2025 and quarterly EPS shift from about US$32 in Q4 2024 to roughly US$160 in Q4 2025, with net income excluding extra...
NasdaqGS:NDSN
NasdaqGS:NDSNMachinery

Assessing Nordson (NDSN) Valuation After Strong One Year Total Shareholder Return

What Nordson’s recent share performance signals for investors Nordson (NDSN) has drawn investor attention after a period of steady gains, with the share price last closing at $283.08 and total return over the past year reported at 62.06%. See our latest analysis for Nordson. Nordson’s share price momentum looks steady rather than abrupt, with a 7.75% 1 month share price return and a 17.45% year to date share price return. The 62.06% 1 year total shareholder return points to strong longer term...
NasdaqGS:FAST
NasdaqGS:FASTTrade Distributors

Evaluating Fastenal (FAST) After Q1 2026 Earnings And Share Price Momentum

Fastenal (FAST) shares are in focus after the company released first quarter 2026 results, reporting sales of US$2,201.7m and net income of US$339.8m, along with higher earnings per share compared with a year earlier. See our latest analysis for Fastenal. The earnings and dividend announcements come after a solid run for the shares, with the year to date share price return of 12.66% and a 1 year total shareholder return of 15.87% pointing to momentum that has built over several years,...
OTCPK:STLE
OTCPK:STLEBanks

Steele Bancorp (OTCPK:STLE) One Off US$12.8m Gain Reshapes Earnings Narrative

Steele Bancorp (OTCPK:STLE) has just posted Q1 2026 results with Q4 2025 numbers showing total revenue of US$13.5 million and basic EPS of US$1.64, capping off a trailing twelve month period where reported earnings grew 410.8%. Over the last year, total revenue has moved from US$4.59 million in Q4 2024 to US$13.5 million in Q4 2025, while trailing EPS climbed from US$2.41 to US$9.15, with much of that uplift tied to a one off US$12.8 million gain and a net profit margin that now sits at...
NYSE:ALV
NYSE:ALVAuto Components

Autoliv Broadens Airbag Reach As Asian Growth And Valuation Gap Stand Out

Autoliv (NYSE:ALV) is expanding beyond traditional car airbags into motorcycle and wearable airbag safety products. The company has introduced its first motorcycle airbag and wearable airbag solutions, targeting riders and other vulnerable road users. Autoliv has recently outperformed in Asian markets such as China, India, and South Korea alongside this product expansion. Autoliv, trading around $121.36, is increasingly tied to broader mobility safety rather than just passenger vehicles...
NYSE:BKSY
NYSE:BKSYProfessional Services

Is It Too Late To Consider BlackSky Technology (BKSY) After Its Recent Share Price Surge?

If you are wondering whether BlackSky Technology at US$37.42 is richly priced or still has room to run, it helps to step back and look at the valuation through a few different lenses. The stock has seen sharp recent moves, with returns of 7.6% over 7 days, 43.4% over 30 days, 79.7% year to date, and very large gains over 12 months at 464.4%, set against a 3 year return of 246.5% and a 5 year return of 53.1% decline. Recent coverage has focused on BlackSky Technology's role as a listed...
NYSE:TPC
NYSE:TPCConstruction

Is It Too Late To Consider Tutor Perini (TPC) After A 327% One-Year Surge?

If you are wondering whether Tutor Perini at around US$84 is still priced attractively after a strong run, you are not alone. That is exactly what this valuation focused review will unpack. The stock has posted returns of 0.7% over the last week, 21.7% over the last month, 21.7% year to date and 327.1% over the past year. This naturally raises questions about how much value is already reflected in the share price. Recent headlines around Tutor Perini have centered on the company winning and...
NYSE:SMA
NYSE:SMASpecialized REITs

A Look At SmartStop Self Storage REIT’s (SMA) Valuation After Recent Share Price Gains

Why SmartStop Self Storage REIT is on investors’ radar SmartStop Self Storage REIT (SMA) has drawn attention after a period of recent share gains, with the stock up around 10% over the past month and about 3% in the past 3 months. At a recent closing price of $33.39 and a market value near $1.8b, SmartStop sits in the mid cap range for U.S. real estate, giving investors a sizeable but still focused exposure to the self storage segment. See our latest analysis for SmartStop Self Storage...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

A Look At C.H. Robinson Worldwide (CHRW) Valuation After Recent Share Price Momentum

Why C.H. Robinson Worldwide is on investors’ radar today C.H. Robinson Worldwide (CHRW) has drawn attention after a period of solid recent returns, including roughly 12% year to date and about 10% over the past year. This performance has prompted closer scrutiny of its freight focused business. See our latest analysis for C.H. Robinson Worldwide. The recent move up to a share price of $183.95, supported by a 7 day share price return of 11.54% and a very large 1 year total shareholder return...
NasdaqGM:NNOX
NasdaqGM:NNOXHealthcare

Nano X Imaging (NNOX) Quarterly Losses Far Exceed US$3.4m Revenue Reinforcing Bearish Narratives

Nano-X Imaging (NNOX) has reported third quarter FY 2025 revenue of US$3.4 million with a basic EPS loss of US$0.21, alongside trailing twelve month revenue of US$12.3 million and a basic EPS loss of US$0.88. The company has seen quarterly revenue move from US$2.7 million in Q2 2024 to US$3.4 million in Q3 2025, while basic EPS has remained in a narrow loss range between roughly US$0.21 and US$0.23 per quarter. This keeps the focus on whether revenue can outgrow persistent losses and...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

If You Believe In Robotics And Automation Stocks Then These Three Trajectories Could Define The Next Cycle

Robotics is moving from science project to real-world workhorse just as investors are juggling inflation worries, oil-price swings, and changing interest rate expectations across major economies. While bond yields, energy markets, and central bank signals keep shifting, the physical AI push is quietly about one thing you can understand very clearly: productivity. This screener focuses on robotics companies that are not just building hardware, but are structured to translate automation demand...